Edesa Biotech, Inc.
General ticker "EDSA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $10.6M (TTM average)
Edesa Biotech, Inc. follows the US Stock Market performance with the rate: 7.2%.
Estimated limits based on current volatility of 2.3%: low 1.68$, high 1.76$
Factors to consider:
- Earnings expected soon, date: 2025-12-12 bmo
- Total employees count: 16 as of 2023
- Top business risk factors: Inability to raise capital, Regulatory and compliance, No commercial products, Operating losses, Labor/talent shortage/retention
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-09-30 to 2026-09-30
- 2024-09-30 to 2025-09-30 estimated range: [2.56$, 7.35$]
- 2025-09-30 to 2026-09-30 estimated range: [1.71$, 5.16$]
Financial Metrics affecting the EDSA estimates:
- Positive: with PPE of -2.3 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -35.14 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Investing cash flow per share per price, % of -0.19 > -0.66
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: 41.86 < Shareholder equity ratio, % of 51.94 <= 63.39
- Positive: Inventory ratio change, % of 0 <= 0
Short-term EDSA quotes
Long-term EDSA plot with estimates
Financial data
| YTD | 2022-09-30 | 2023-09-30 | 2024-09-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $18.37MM | $9.22MM | $7.01MM |
| Operating Income | $-18.37MM | $-9.22MM | $-7.01MM |
| Non-Operating Income | $0.82MM | $0.85MM | $0.85MM |
| R&D Expense | $13.34MM | $4.79MM | $2.88MM |
| Income(Loss) | $-17.55MM | $-8.37MM | $-6.17MM |
| Taxes | $0.00MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $-17.55MM | $-8.37MM | $-6.17MM |
| Stockholders Equity | $9.39MM | $7.05MM | $1.98MM |
| Assets | $11.58MM | $8.89MM | $3.81MM |
| Operating Cash Flow | $-12.28MM | $-6.64MM | $-4.89MM |
| Capital expenditure | $0.01MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.01MM | $0.00MM | $-0.03MM |
| Financing Cash Flow | $11.63MM | $4.83MM | $0.59MM |
| Earnings Per Share** | $-8.37 | $-2.93 | $-1.93 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.